Litcius/Paper detail

GLP-1 agonists to slow down Parkinson’s progression? The quest continues

Bastiaan R. Bloem, Eric A. Macklin, Michael A. Schwarzschild

2025Med12 citationsDOI

Topics & Concepts

Parkinson's diseaseNeurosciencePsychologyMedicineInternal medicineDiseaseParkinson's Disease Mechanisms and TreatmentsDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer
GLP-1 agonists to slow down Parkinson’s progression? The quest continues | Litcius